Newsroom
Newsroom
Blog Posts
Synthetic chemistry is an essential part of drug development, opening the door for scientists to create complex small molecules with specific properties. Small molecule drugs...
Press Releases
Antheia, the pharmaceutical ingredient manufacturer transforming supply chains, today announced the appointment of John Nicols to Chair its Board of Directors. Nicols joins co-founders Dr....
Industry News
Our co-founder and CEO, Christina Smolke, was named to Forbes’ list of top ten women founders taking the synthetic biology world by storm. From her...
Blog Posts
We’ve recently welcomed Jesse Ahrendt, our new Senior Vice President of Quality Assurance and Regulatory Affairs, who will lead our quality and regulatory efforts. He...
Blog Posts
At Antheia, we spend a lot of time talking about synthetic biology due to the nature of our work engineering yeast to produce active pharmaceutical...
Blog Posts
This year has been ripe with growth, major achievements, and opportunities to showcase who and what make Antheia the visionary business it is. Nearly eight...
Blog Posts
Synthetic chemistry is an essential part of drug development, opening the door for scientists to create complex small molecules with specific properties. Small molecule drugs...
Press Releases
Antheia, the pharmaceutical ingredient manufacturer transforming supply chains, today announced the appointment of John Nicols to Chair its Board of Directors. Nicols joins co-founders Dr....
Industry News
Our co-founder and CEO, Christina Smolke, was named to Forbes’ list of top ten women founders taking the synthetic biology world by storm. From her...
Blog Posts
We’ve recently welcomed Jesse Ahrendt, our new Senior Vice President of Quality Assurance and Regulatory Affairs, who will lead our quality and regulatory efforts. He...
Blog Posts
At Antheia, we spend a lot of time talking about synthetic biology due to the nature of our work engineering yeast to produce active pharmaceutical...
Blog Posts
This year has been ripe with growth, major achievements, and opportunities to showcase who and what make Antheia the visionary business it is. Nearly eight...
Industry News
Led by Viking Global Investors, the Series B round will be used to bring Antheia's first pharmaceutical compounds to market, expand its pipeline and scale...
Industry News
Menlo Park, California-based Antheia, a synthetic biology company, has raised $73 million in Series B financing. Viking Global Investors led the round with participation from...
Industry News
Antheia, a synthetic biology company enabling next-generation plant-inspired medicines, has raised $73 million in Series B financing....
Industry News
Antheia has raised $73 million to support the commercialization of its first pharmaceutical compound and the scale-up of production of active pharmaceutical ingredients and key...
Industry News
Company's SynBio platform enables manufacturing of complex plant-based drugs Biomanufacturing and synthetic biology (SynBio) manufacturing platforms have the potential to create more resilient supply chains...
Industry News
An expert from synthetic biology tech firm Antheia offers ways to rethink current sourcing and manufacturing strategies to tackle current and future woes......
Blog Posts
For the final installation in our “Meet the Team” series, we hear from Olivia, Khurram and Vicky, who lead our operations. This team is the...
Blog Posts
For decades, synthetic biology has promised to make manufacturing more efficient, sustainable, and responsive to sudden changes in supply and demand. It has the potential...
Blog Posts
For the next installation in the “Meet the Team” series, we hear from Yuki Higa, a Process Engineer at Antheia. Read on to learn about...
Blog Posts
We’re excited for the next interview in our “Meet the Team” series! We hear from Cat Cleto, a Fermentation Research Associate, on her path from...
Blog Posts
Earlier this month, my cofounder Kristy Hawkins and I presented at SynBioBeta 2020, the flagship conference for the synthetic biology community. This year’s virtual event...
Blog Posts
As a part of our new “Meet the Team” series, we hear from Ken Takeoka, Antheia’s very first employee and a Scientist III. Read on...